Immunotherapy for Multiple Myeloma: From Antibodies to CAR T–Cell Therapy
| Overview / Abstract: |
Multiple myeloma remains incurable, but the number and type of treatments continue to expand rapidly. A development that holds particular promise for patients with relapsed/refractory myeloma is the emergence of immunotherapy options such as antibody-based therapies, bispecific T-cell engagers, and chimeric antigen receptor T–cell therapy. Successful implementation of myeloma immunotherapy into practice, however, requires oncology nurses and advanced practitioners to be current on new and emerging immunotherapeutic agents and strategies. This enduring CNE activity provides information on the newest myeloma immunotherapy treatments, including their rationale for use and results from ongoing clinical studies. |
|
Expiration |
Oct 29, 2021 |
|
Discipline(s) |
Nurse Practitioner , Nursing CNE |
|
Format |
Online, Webinar / Webcast / Video |
|
Credits / Hours |
Purdue University Continuing Nursing Education is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. This activity is approved for 1.0 Nursing Contact Hour. |
|
Accreditation |
ANCC |
|
Presenters / Authors / Faculty |
Colleen Harker Erb, MSN, CRNP, ACNP-BC, AOCNP Angela M. Vickroy, ANP-BC, OCN |
|
Activity Specialities / Related Topics |
Education / Teaching, Hematology, Oncology / Cancer / Radiation Therapy |
|
Sponsors / Supporters / Grant Providers |
This activity is supported by educational grants from Bristol Myers Squibb; Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; Karyopharm Therapeutics, Inc; and Sanofi Genzyme. |
|
Keywords / Search Terms |
RedMedEd RedMedEd Free, Nursing, Nurse, Rush, Multiple Myeloma Research Foundation, RedMedEd MMRF, MM, multiple myeloma, myeloma, disease, best practices, game, cytogenetic, molecular, staging test, mechanisms of action, safety, indicated uses, toxicity, patients, slide effects Free CE CME Free CE CME |
|